News

Title Content Date
How sleep strengthens the immune system Scientists at the University of Tübingen discover new mechanism that supports our immune system during sleep 12.02.2019
CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical Drug development veteran to focus on advancing the company’s preclinical portfolio of programs in naturally optimized mRNA 04.02.2019
Novel unusual sugar from cyanobacteria acts as natural herbicide Chemists and microbiologists at Tübingen University discover sugar molecule that inhibits the growth of plants and microorganisms and is harmless to human cells ‒ An alternative to controve 01.02.2019
Blockstart makes SMEs stronger with blockchain solutions The new European project Blockstart helps small- to medium-sized enterprises (SMEs) strengthen their competitive positions through the use of blockchain technology. 30.01.2019
A safer way to correct faulty DNA University of Tübingen researchers take RNA editing a step closer to treating hereditary diseases 28.01.2019
CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer Drug development veteran to lead CureVac’s global product development efforts as the company looks to advance its pipeline of mRNA-based products 28.01.2019
Second Codex4SMEs double session held at IBBL IBBL (Integrated Biobank of Luxembourg) is pleased to be hosting the second Codex4SMEs double session at its premises in Dudelange, Luxembourg. 23.01.2019
From Stuttgart to the world: Fraunhofer IPA turns 60 "Future is our product" is the motto of the Fraunhofer Institute for Manufacturing Engineering and Automation IPA. 21.01.2019
CureVac Announces U.S. Patent Grant for mRNA Vaccination of Infants Against RSV CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced that the U.S. 08.01.2019
Atriva Therapeutics announces first closing of series A financing round Funds to advance antiviral lead product ATR-002 into clinical trials 03.01.2019

Pages